I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
The Surrey Heartland Integrated Care System Area Prescribing Committee have agreed to adopt the SERMOG high-cost drugs pathway.for adiults with psoriasis
The Prescribing Clinical Network recommends guselkumab as a treatment option for treating moderate to severe plaque psoriasis in line with NICE TA521 (June 2018).
Guselkumab for this indication will be considered as RED on the traffic light status (treatment should be initiated and continued by specialist clinicians)
Guselkumab is a payment by results excluded drug and specialists will be required to notify commissioners of initiation and response to treatment using the tick box proformas available on the blueteq system.
Other Indications
Below are listed other indications that Guselkumab is used to treat.
